Multimodal Nociception Tracking Under Anesthesia
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for tracking nociception under anesthesia are inadequate due to reliance on single physiological signals, unimodal models, and limited validation, leading to inaccurate pain management and potential overdosing or underdosing of anesthetic agents.
Innovation Solution
A multimodal approach using concurrent measurements of electrodermal activity, heart rate, and heart rate variability, processed through point process models and state space frameworks to provide a quantitative, objective assessment of nociceptive state, allowing for precise adjustment of anesthetic dosages.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If single physiological signals are used to track nociception, then device complexity is reduced, but measurement precision deteriorates
Solution Approach 1:
The patent combines multiple physiological signals (electrodermal activity, heart rate, heart rate variability) into a unified nociception metric using a multimodal model. This merging of multiple measurement modalities improves measurement precision by capturing different aspects of the autonomic response to nociceptive stimuli, while the signals are integrated through a coordinated measurement system that manages complexity.
Solution Approach 2:
The measurement system is designed to simultaneously capture multiple physiological parameters (EDA, heart rate, HRV) that all relate to nociception assessment. This multi-functional approach allows a single integrated system to perform comprehensive nociception tracking rather than requiring separate specialized devices for each parameter.
2Reliability
If unimodal models are used for nociception assessment, then model complexity is reduced, but reliability deteriorates
Solution Approach 1:
The patent employs a multimodal model that integrates multiple physiological modalities (electrodermal activity, heart rate, heart rate variability) to assess nociception. This combination of modalities improves reliability by providing a more comprehensive and robust assessment that is less susceptible to artifacts or limitations of any single signal, while the model structure manages complexity through systematic integration.
Solution Approach 2:
The nociception assessment model functions as a composite system that combines multiple physiological indicators into a unified metric. Like composite materials that combine different substances to achieve superior properties, this composite model combines multiple physiological signals to achieve more reliable nociception assessment than any single signal could provide alone.
3Measurement precision
If limited validation is performed, then validation time is reduced, but measurement precision deteriorates
Solution Approach 1:
The patent performs comprehensive validation of the multimodal nociception metric before clinical implementation. This preliminary validation action includes testing the model against ground truth nociception measurements and evaluating its performance across different surgical conditions. By completing thorough validation in advance, the system ensures high measurement precision is achieved and verified, preventing the need for extensive post-implementation adjustments.
Data Source
AI summary
Systems and methods for tracking sympathetic-driven arousal state (SDAS) including nociception under anesthesia is described herein. The method includes obtaining heart rate variability and electrodermal activity of a subject. Point process models are generated for the heart rate variability and the electrodermal activity. A multimodal approach is implemented to determine a state space framework based on these point process models. SDAS can be estimated using the state space framework. In some implementations, an anesthesiologist can modify the dosage of drugs administered to the subject based on this estimation.